• FDA OKs higher dose insulin glargine for kids, plus more top stories in endocrinology

    9 monthes ago - By Healio

    The top stories in endocrinology last week included the FDA's approval of a higher dose insulin glargine for children with diabetes, along with new data that suggest the readmission rate after pituitary surgery in the United States has remained unchanged since 2010.
    Find all of last week's top stories in endocrinology news here.
    FDA approves higher-dose insulin glargine for children with diabetes
    The FDA recently approved an expanded indication for insulin glargine injection 300 U/mL to improve glucose response in children aged 6 years and older with diabetes, according to a press
    Read more ...